PTT-4256

N/A

Report date: 2024/10/11 20:00:59
NMEFirst In Class

Base Information

Drug NamePTT-4256
Drug Alias NamePTT-4256
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor 65 inhibitors
TargetsG-protein coupled receptor 65
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPathios Therapeutics Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPathios Therapeutics Pty LtdPathios Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A